l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors

[1]  N. Mercuri,et al.  Cognitive Impairment and Dentate Gyrus Synaptic Dysfunction in Experimental Parkinsonism , 2014, Biological Psychiatry.

[2]  D. Manahan‐Vaughan,et al.  Locus Coeruleus Stimulation Facilitates Long-Term Depression in the Dentate Gyrus That Requires Activation of β-Adrenergic Receptors , 2014, Cerebral cortex.

[3]  P. Calabresi,et al.  New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease , 2013, The Lancet Neurology.

[4]  Arafat Angulo-Perkins,et al.  Sustained Transcription of the Immediate Early Gene Arc in the Dentate Gyrus after Spatial Exploration , 2013, The Journal of Neuroscience.

[5]  P. Calabresi,et al.  Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease , 2012, The Journal of Neuroscience.

[6]  D. Manahan‐Vaughan,et al.  Dopamine D1/D5 Receptors Mediate Informational Saliency that Promotes Persistent Hippocampal Long-Term Plasticity , 2012, Cerebral cortex.

[7]  H. Braak,et al.  Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  F. Piras,et al.  Hippocampal abnormalities and memory deficits in Parkinson disease , 2012, Neurology.

[9]  Stefano Puglisi-Allegra,et al.  Mechanisms Underlying the Impairment of Hippocampal Long-term Potentiation and Memory in Experimental Parkinson's Disease Materials and Methods Procedure for L-dopa Treatments Immunohistological Procedure Behavioural Procedure , 2022 .

[10]  F. Gage,et al.  Dopaminergic Modulation of Cortical Inputs during Maturation of Adult-Born Dentate Granule Cells , 2011, The Journal of Neuroscience.

[11]  M. Larkum,et al.  Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells , 2010, Proceedings of the National Academy of Sciences.

[12]  J. Leverenz,et al.  Profile of Cognitive Impairment in Parkinson's Disease , 2010, Brain pathology.

[13]  A. Benabid,et al.  De novo and long-term l-Dopa induce both common and distinct striatal gene profiles in the hemiparkinsonian rat , 2009, Neurobiology of Disease.

[14]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[15]  Michael R. Hunsaker,et al.  The role of the dentate gyrus, CA3a,b, and CA3c for detecting spatial and environmental novelty , 2008, Hippocampus.

[16]  P. Calabresi,et al.  l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation , 2008, Neurobiology of Disease.

[17]  Stefano Puglisi-Allegra,et al.  The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. , 2007, Cerebral cortex.

[18]  Girstaute Dagyte,et al.  Sustained Arc/Arg3.1 Synthesis Controls Long-Term Potentiation Consolidation through Regulation of Local Actin Polymerization in the Dentate Gyrus In Vivo , 2007, The Journal of Neuroscience.

[19]  Denise Manahan-Vaughan,et al.  Hippocampal long-term depression: master or minion in declarative memory processes? , 2007, Trends in Neurosciences.

[20]  Anastassios V. Tzingounis,et al.  Arc/Arg3.1: Linking Gene Expression to Synaptic Plasticity and Memory , 2006, Neuron.

[21]  W. Abraham,et al.  Induction and activity-dependent reversal of persistent LTP and LTD in lateral perforant path synapses in vivo , 2006, Neurobiology of Learning and Memory.

[22]  R. Malenka,et al.  Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome , 2004, The Journal of Neuroscience.

[23]  Thomas Straube,et al.  Requirement of β‐adrenergic receptor activation and protein synthesis for LTP‐reinforcement by novelty in rat dentate gyrus , 2003 .

[24]  J. Frey,et al.  Bidirectional modulation of long-term potentiation by novelty-exploration in rat dentate gyrus , 2003, Neuroscience Letters.

[25]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[26]  M. Sasa,et al.  Inhibition by L-3,4-dihydroxyphenylalanine of hippocampal CA1 neurons with facilitation of noradrenaline and gamma-aminobutyric acid release. , 2001, European journal of pharmacology.

[27]  J. Pierce,et al.  β‐Adrenergic receptors primarily are located on the dendrites of granule cells and interneurons but also are found on astrocytes and a few presynaptic profiles in the rat dentate gyrus , 2000, Synapse.

[28]  F. Gage,et al.  Mammalian neural stem cells. , 2000, Science.

[29]  W. Abraham,et al.  A double dissociation within the hippocampus of dopamine D1/D5 receptor and β-adrenergic receptor contributions to the persistence of long-term potentiation , 1999, Neuroscience.

[30]  R. Anwyl,et al.  Conditions for the induction of long-term potentiation and long-term depression by conjunctive pairing in the dentate gyrus in vitro. , 1997, Journal of neurophysiology.

[31]  K. Inokuchi,et al.  Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain , 1997, Neuroreport.

[32]  S Laroche,et al.  Heterosynaptic LTD and depotentiation in the medial perforant path of the dentate gyrus in the freely moving rat. , 1997, Journal of neurophysiology.

[33]  Mark G. Packard,et al.  The dopaminergic mesencephalic projections to the hippocampal formation in the rat , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  J. P. Huston,et al.  The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments , 1996, Progress in Neurobiology.

[35]  M. Witter,et al.  Entorhinal-Hippocampal Interactions Revealed by Real-Time Imaging , 1996, Science.

[36]  C. Verney,et al.  Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study , 1994, Brain Research.

[37]  W. Schultz,et al.  Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  Wade K. Smith,et al.  Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.

[39]  R. Yanagihashi,et al.  Studies on long-term potentiation of the population spike component of hippocampal field potential by the tetanic stimulation of the perforant path in rats: effects of a dopamine agonist, SKF-38393 , 1992, Brain Research.

[40]  H. Akil,et al.  Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization- receptor autoradiographic analysis , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  L. Descarries,et al.  Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  Wade K. Smith,et al.  Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.

[43]  K. S. Bankiewicz,et al.  A 6-hydroxydopamine-induced selective parkinsonian rat model , 1989, Brain Research.

[44]  Y. Goshima,et al.  Transmitter‐Like Release of Endogenous 3,4‐Dihydroxyphenylalanine from Rat Striatal Slices , 1988, Journal of neurochemistry.

[45]  J. Sarvey,et al.  Norepinephrine regulates long-term potentiation of both the population spike and dendritic EPSP in hippocampal dentate gyrus , 1987, Brain Research Bulletin.

[46]  Y. Goshima,et al.  Biphasic actions of l-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices , 1986, Neuroscience Letters.

[47]  Floyd E. Bloom,et al.  The Biochemical Basis of Neuropharmacology , 1978 .

[48]  M. Henning,et al.  Central hypotensive effect of L‐3,4‐dihydroxyphenylalanine in the rat , 1970, The Journal of pharmacy and pharmacology.

[49]  R. Tissot,et al.  Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain , 1968, Experientia.

[50]  C. Léránth,et al.  Extrinsic afferent systems to the dentate gyrus. , 2007, Progress in brain research.

[51]  David Hsu,et al.  The dentate gyrus as a filter or gate: a look back and a look ahead. , 2007, Progress in brain research.

[52]  G. Chiara,et al.  Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat , 2005, Psychopharmacology.

[53]  C. Harley.  Norepinephrine and Dopamine as Learning Signals , 2004, Neural plasticity.

[54]  K. Jellinger,et al.  New developments in the pathology of Parkinson's disease. , 1990, Advances in neurology.

[55]  Y. Goshima,et al.  L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. , 1990, Japanese journal of pharmacology.

[56]  R. Duvoisin,et al.  Biochemical Models of Parkinson’s Disease , 1989 .

[57]  K. Jellinger,et al.  Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.